A phase I/II study of nanoliposomal irinotecan and carboplatin in patients with advanced or metastatic, poorly differentiated gastroenteropancreatic neuroendocrine carcinoma characterized by tissue and liquid next-generation sequencing.

被引：0

作者：

Chiang, Nai-Jung ^{[1
]}

Li, Chien-Feng ^{[2
]}

Bai, Li-Yuan ^{[3
]}

Huang, Chien-Jui ^{[4
]}

Yen, Chih Chieh ^{[5
]}

Hsiao, Chin-Fu ^{[6
]}

Wu, Li-Ching ^{[7
]}

Chen, Ming Huang

机构：

[1] Chi Mei Med Ctr, Dept Pathol, Tainan, Taiwan

[2] China Med Univ Hosp, Taichung, Taiwan

[3] China Med Univ, Taichung, Taiwan

[4] Natl Cheng Kung Univ Hosp, Tainan, Taiwan

[5] Natl Cheng Kung Univ Hosp, Tainan, Taiwan

[6] Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan

[7] Chi Mei Med Ctr, Ctr Precis Med, Tainan, Taiwan

来源：

关键词：

D O I：

10.1200/JCO.2024.42.23_suppl.52

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：52 / 52

页数：1